BGIM
CORZ icon

Boussard & Gavaudan Investment Management’s Core Scientific CORZ Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-137,319
Closed -$2.47M – 99
2025
Q3 		$2.47M Buy
+137,319
New +$2.01M 0.31% 51

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

Boussard & Gavaudan Investment Management's CORZ Position: Q4 2025 in Review

Boussard & Gavaudan Investment Management sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 137,319 shares — an estimated $2.47M sold.

Boussard & Gavaudan Investment Management first reported a position in CORZ in Q3 2025 and held it in 1 quarter. The position peaked at $2.47M in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Boussard & Gavaudan Investment Management reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 137,319 Core Scientific shares in Q4 2025, an estimated $2.47M.
  • Boussard & Gavaudan Investment Management first reported a position in Core Scientific in Q3 2025 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Core Scientific position peaked at $2.47M in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.